In Vitro Activities of Daptomycin-, Vancomycin-, and Teicoplanin-Loaded Polymethylmethacrylate against Methicillin-Susceptible, Methicillin-Resistant, and Vancomycin-Intermediate Strains of Staphylococcus aureus

被引:68
作者
Chang, Yuhan [1 ,2 ]
Chen, Wen-Chien [1 ,2 ]
Hsieh, Pang-Hsin [1 ,2 ]
Chen, Dave W. [1 ,2 ]
Lee, Mel S. [1 ,2 ]
Shih, Hsin-Nung [1 ,2 ]
Ueng, Steve W. N. [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Orthopaed Surg, Tao Yuan, Taiwan
[2] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan
关键词
ACRYLIC BONE-CEMENT; INFECTIONS; OSTEOMYELITIS; ELUTION; CALCIUM;
D O I
10.1128/AAC.05312-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The objective of this study was to evaluate the antibacterial effects of polymethylmethacrylate (PMMA) bone cements loaded with daptomycin, vancomycin, and teicoplanin against methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-intermediate Staphylococcus aureus (VISA) strains. Standardized cement specimens made from 40 g PMMA loaded with 1 g (low-dose), 4 g (middle-dose) or 8 g (high-dose) antibiotics were tested for elution characteristics and antibacterial activities. The patterns of release of antibiotics from the cement specimens were evaluated using in vitro broth elution assay with high-performance liquid chromatography. The activities of broth elution fluid against different Staphylococcus aureus strains (MSSA, MRSA, and VISA) were then determined. The antibacterial activities of all the tested antibiotics were maintained after being mixed with PMMA. The cements loaded with higher dosages of antibiotics showed longer elution periods. Regardless of the antibiotic loading dose, the teicoplanin-loaded cements showed better elution efficacy and provided longer inhibitory periods against MSSA, MRSA, and VISA than cements loaded with the same dose of vancomycin or daptomycin. Regarding the choice of antibiotics for cement loading in the treatment of Staphylococcus aureus infection, teicoplanin was superior in terms of antibacterial effects.
引用
收藏
页码:5480 / 5484
页数:5
相关论文
共 21 条
  • [1] MRSA - the tip of the iceberg
    Appelbaum, PC
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 3 - 10
  • [2] Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection
    Bowker, Karen E.
    Noel, Alan R.
    MacGowan, Alasdair P.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (05) : 1044 - 1051
  • [3] Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens
    Carpenter, CF
    Chambers, HF
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (07) : 994 - 1000
  • [4] Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
    Chang, S
    Sievert, DM
    Hageman, JC
    Boulton, ML
    Tenover, FC
    Downes, FP
    Shah, S
    Rudrik, JT
    Pupp, GR
    Brown, WJ
    Cardo, D
    Fridkin, SK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) : 1342 - 1347
  • [5] Cefuroxime-impregnated cement in primary total knee arthroplasty - A prospective, randomized study of three hundred and forty knees
    Chiu, FY
    Chen, CM
    Lin, CFJ
    Lo, WH
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (05) : 759 - 762
  • [6] Management of bone and joint infections due to Staphylococcus aureus
    Davis, JS
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 : S79 - S96
  • [7] Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests
    Fuchs, PC
    Barry, AL
    Brown, SD
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (01) : 51 - 58
  • [8] Septic arthritis
    Goldenberg, DL
    [J]. LANCET, 1998, 351 (9097) : 197 - 202
  • [9] Local antibiotic delivery vehicles in the treatment of musculoskeletal infection
    Hanssen, AD
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (437) : 91 - 96
  • [10] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
    Hiramatsu, K
    Hanaki, H
    Ino, T
    Yabuta, K
    Oguri, T
    Tenover, FC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) : 135 - 136